Abstract
The GL261 glioma is representative of a carcinogen-induced mouse syngeneic glioma model. This model represents one of the very few brain tumor models developed in immunocompetent animals that has growth characteristics similar to human GBM. The ideal animal model should share the invasive properties that the human GBM displays, since this is a major reason for the failure of current treatment strategies. Here we demonstrate, through a detailed comparison with human GBM, that the murine GL261 glioma closely mimics its human counterpart in a number of significant ways, but most importantly in its invasive and angiogenic properties representing the relevant biology of human GBMs. Therefore, it should prove to be a valuable preclinical model for testing novel drugs and therapeutic strategies that inhibit glioma invasion and angiogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe T, Terada K, Wakimoto H, et al. (2003) PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli. Cancer Res 63:2300–2305
Ausman JI, Shapiro WR, Rall DP (1970) Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res 30:2394–2400
Brat DJ, Castellano-Sanchez AA, Hunter SB, et al. (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920–927
Cha S, Johnson G, Wadghiri YZ, et al. (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49:848–855
Choe G, Horvath S, Cloughesy TF, et al. (2003) Analysis of the phosphatidylinositol 3’-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63:2742–2746
Davies MA, Lu Y, Sano T, et al. (1998) Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58:5285–5290
Ermoian RP, Furnis CS, Lamborn KR, et al. (2002) Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8:1100–1106
Eshleman JS, Carlson BL, Mladek AC, et al. (2002) Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. Cancer Res 62:7291–7297
Ehtesham M, Winston JA, Kabos P, et al. (2006). CXCR4 expression mediates glioma cell invasiveness. Oncogene 25:2801–2806
Forsythe JA, Jiang BH, Iyer NV, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613
Glick RP, Lichtor T, de Zoeten E, et al. (1999) Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2. Neurosurgery 45:867–874
Heimberger AB, Crotty LE, Archer GE, et al. (2000) Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 103:16–25
Heimberger AB, Learn CA, Archer GE, et al. (2002) Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa). Clin Cancer Res 8:3496–3502
Hellums EK, Markert JM, Parker JN, et al. (2005) Increased efficacy of an interleukin-12 secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro-Oncol 7:213–224
Hesselager G, Uhrbom L, Westermark B, et al. (2003) Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 63:4305–4309
Holash J, Maisonpierre PC, Compton D, et al. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994–1998
Holland EC, Celestino J, Dai C, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55–57
Hu B, Guo P, Fang Q, et al. (2003) Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci 100:8904–8909
Hu B, Jarzynka MJ, Guo P, et al. (2006) Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66:775–783
Kjaergaard J, Tanaka J, Kim JA, et al. (2000) Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res 60:5514–5521
Krishnamachary B, Berg-Dixon S, Kelly B, et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63:1138–1143
Learn CA, Grossi PM, Schmittling RJ, et al. (2007) Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity. J Neuroimmunol 182:63–72
Lumniczky K, Desaknai S, Mangel L, et al. (2002) Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model. Cancer Gene Ther 9:44–52
Martinez-Murillo R and Martinez A. (2007) Standardization of an orthotopic mouse brain tumor model following transplantation of CT-2A astrocytoma cells. Histol Histopathol 22:1309–1326
Miller CR, Williams CR, Buchsbaum DJ, et al. (2002) Intratumoral 5-fluorouracil produced by cytosine deaminase/5-flurocytosine gene therapy is effective for experimental human glioblastomas. Cancer Res 62:773–780
Miyatake S, Martuza RL, Rabkin SD (1997) Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Cancer Gene Ther 4:222–228
Mohanam S, Cvhandrasekar N, Yanamandra N, et al. (2002) Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene 21:7824–7830
Nelson SJ, Cha S (2003) Imaging Glioblastoma Multiforme. Cancer J 9:134–145
Newcomb EW, Tamasdan C, Entzminger Y, et al. (2004) Flavopiridol inhibits the growth of GL261 gliomas in vivo: Implications for malignant glioma therapy. Cell Cycle 3:230–234
Newcomb EW, Demaria S, Lukyanov Y, et al. (2006) The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 tumors. Clin Cancer Res 12:4730–4737
Peterson DL, Sheridan PJ, Brown WE, Jr. (1994) Animal models for brain tumors: historical perspectives and future directions. J Neurosurg 80:865–876
Pichiule P, Chavez JC, LaManna JC. (2004) Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279:12171–12180
Plate KH, Breier G, Weich HA, et al. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848
Plautz GE, Touhalisky JE, Shu S. (1997) Treatment of murine gliomas by adoptive transfer ex vivo activated tumor-draining lymph node cells. Cell Immunol 178:101–107
Reilly KM, Loisel DA, Bronson RT, et al. (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26:109–113
Reilly KM, Jacks T (2001) Genetically engineered mouse models of astrocytoma: GEMs in the rough? Semin Cancer Biol 11:177–190
Sampson JN, Ashley DM, Archer GE, et al. (1997) Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery 41:1365–1372
Scheid MN, Woodgett Jr (2003) Unraveling the activation mechanisms of protein kinase B/Akt. FEBS Letts 546:108–112
Schold SC, Jr., Bigner DD (1983) A review of animal brain tumor models that have been used for therapeutic studies. In Walker MD ed. Oncology of the Nervous System. Boston: Nijhoff. p.31–63
Seligman AM, Shear MJ (1939) Studies in carcinogenesis. VIII. Experimental production of brain tumors in mice with methylcholanthrene. Am J Cancer 37:364–395
Serano RD, Pegram CN, Bigner DD. (1980) Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA). Acta Neuropathol 51:53–64
Shweiki D, Itin A, Soffer D, et al. (1992) Vasular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845
Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev Cancer 2:489–501
Weiner NE, Pyles RB, Chalk CL, et al. (1999) A syngeneic mouse glioma model for study of glioblastoma therapy. J Neuropathol Exp Neurol 58:54–60
Weiss WA, Israel M, Cobbs C, et al. (2002) Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene 21:7453–7463
Weissenberger J, Steinbach JP, Malin G, et al. (1997) Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene 14:2005–2013
Wiranowska M, Tresser N, Saporta S (1998) The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro. Anticancer Res 18:3331–3338
Xiao A, Wu H, Pandolfi PP, et al. (2002) Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1:157–168
Yu JS, Burwick JA, Dranoff G, et al. (1997) Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum Gene Ther 8:1065–1072
Zagzag D, Zhong H, Scalzitti JM, et al. (2000a) Expression of hypoxia-inducible factor 1α in human brain tumors: Association with angiogenesis, invasion and progression. Cancer 88:2606–2618
Zagzag D, Amirnovin R, Greco MA, et al. (2000b) Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis. Lab Invest 80:837–849
Zagzag D, Miller DC, Chiriboga L, Yee H, et al. (2003) Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo. Brain Pathol 13:34–37
Zagzag D, Lukyanov Y, Lan L, et al. (2006) Hypoxia-inducible factor-1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221–1232
Zagzag D, Esencay M, Mendez O, et al. (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol 173:545–560
Zimmerman H, Arnold H. (1941) Experimental brain tumors. I. Tumors produced with methylcholanthrene. Cancer Res 1:919–938
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Newcomb, E.W., Zagzag, D. (2009). The Murine GL261 Glioma Experimental Model to Assess Novel Brain Tumor Treatments. In: Meir, E. (eds) CNS Cancer. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-60327-553-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-60327-553-8_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-552-1
Online ISBN: 978-1-60327-553-8
eBook Packages: MedicineMedicine (R0)